Jeuveau®

Jeuveau is a cosmetic injectable approved by the FDA specifically for treating moderate to severe glabellar lines, commonly known as frown lines, which appear between the eyebrows. Developed by the company Evolus, Jeuveau is a purified form of botulinum toxin type A, similar to other neuromodulators like BotoxÒ. However, it is engineered using a proprietary manufacturing process to target aesthetic applications, which may make it an appealing choice for individuals seeking a specialized approach to facial rejuvenation.

Jeuveau works by temporarily inhibiting the activity of specific facial muscles that cause dynamic wrinkles, those formed by repeated facial expressions. When injected into targeted areas, Jeuveau blocks the signals from nerves to muscles, preventing them from contracting. As a result, the muscles relax, and the overlying skin smooths out, reducing the appearance of wrinkles. This effect typically lasts several months, after which patients can opt for additional treatments to maintain their desired results.

At Palo Alto Dermatology Institute, Jeuveau is primarily used for treating glabellar lines between the eyebrows. However, it may be applied to other facial areas prone to expression lines, such as:

• Horizontal forehead lines
• Crow’s feet (lines at the outer corners of the eyes)
• Smile lines around the mouth

The treatment plan is personalized for each patient to ensure optimal results that harmonize with their natural facial expressions and aesthetic goals.

First the treatment area is cleansed and, if necessary, a topical anesthetic is applied to enhance comfort. Then Jeuveau is injected directly into the targeted muscles using a fine needle. Patients may feel a slight pinching sensation, but discomfort is minimal. Following the procedure, patients are advised to avoid strenuous activities, rubbing the treated areas, and lying down for a few hours to ensure optimal results.

Results begin to appear within a few days, with the full effect is typically visible after one to two weeks. Patients appreciate the convenience and quick recovery associated with Jeuveau treatments, making it an ideal option for those with busy lifestyles.

Jeuveau offers numerous aesthetic and practical benefits for individuals seeking a non-surgical approach to facial rejuvenation. Key benefits include:

• Effective reduction of dynamic wrinkles, such as frown lines and forehead lines
• Natural-looking, smooth skin that enhances youthful appearance
• Short procedure time and minimal recovery period
• Results that can last three to six months, depending on individual response
• Customizable treatment that allows patients to maintain control over their aesthetic outcomes

At Palo Alto Dermatology Institute, we prioritize each patient’s unique needs, delivering precise and aesthetically balanced results that enhance natural beauty.

While Jeuveau is generally well-tolerated, as with any cosmetic treatment, there are potential side effects. Common side effects may include:

• Temporary redness and swelling at the injection site which usually resolves with a few hours
• Minor bruising in some cases
• Mild headache or discomfort in the treated area

Most side effects are temporary, subsiding within a few hours to a couple of days. However, in rare cases, more severe reactions like eyelid drooping, allergic responses, or muscle weakness may occur. Our dermatology team is available to address any concerns and provide aftercare guidance to ensure a safe, positive experience.

Jeuveau, commonly referred to as “Newtox,” is similar to other neurotoxins like BotoxÒ, DysportÒ, and XeominÒ, in that it is a purified form of botulinum toxin type A designed to reduce dynamic wrinkles. However, it also has distinguishing characteristics that make it appealing for certain patients, particularly those focused solely on aesthetic applications.

Both Jeuveau and Botox contain Botulinum toxin, but their formulations differ. Jeuveau is a purified form of botulinum toxin similar to Botox, but it is engineered using a proprietary manufacturing process to target aesthetic applications, which may make it an appealing choice for individuals seeking a specialized approach to facial rejuvenation.

Like Botox, results are visible within a few days to a week, but Jeuveau results may appear slightly faster. The duration of Jeuveau’s effects is similar to Botox, typically lasting about three to six months. However, individual response can vary, and some patients report longer-lasting results with Jeuveau, although it is ultimately patient-dependent.

The injectable technique is similar across neurotoxins, yet some providers find Jeuveau to provide a smoother, more natural appearance, which may be due to its specific formulation or purity level. These subtle distinctions can make it a preferred choice for patients prioritizing nuanced results in specific areas of the face.

Overall, Jeuveau offers a specialized, cosmetic-focused option in the neuromodulator market, with many similarities to Botox but distinct in its branding and market focus. For patients at Palo Alto Dermatology Institute seeking wrinkle reduction, Jeuveau may be an ideal choice, particularly for those interested in a high-purity, aesthetic-focused neuromodulator. Our team can guide patients through these choices to ensure the right neurotoxin for their unique aesthetic goals and preferences.